Probiotic manipulation of the gut microbiota in relation to inheritance in mice models by Jensen, Diana Worm et al.
 1 
Probiotic manipulation of the gut 
microbiota in relation to 
inheritance in mice models 
Roskilde University  
Spring 2015 
Natural Science Bachelor Project 
Supervisor: Kenneth Klingenberg Barfod 
Christian B. Rasmussen 
Diana Worm Jensen 
Farah Naz Rasool 
Kira Riber Mygind 
Naba Hassan Al-Sari 
Yasemin Özen 
   
  
1 
 
The cover image shows the bacteria Bifidobacterium  
 
 
 
 
 
 
 
 
 
 
  
   
  
2 
 
 
 
 
 
 
 
Acknowledgements 
We would like to thank our supervisor Post. Doc. Kenneth Klingenberg Barfod at 
Roskilde University, National Research Center For Working Environment and Statens 
Serum Institut for guidance in this bachelor project. We want to thank the National 
Research Center For Working Environment and Statens Serum Institut for providing 
laboratories and materials. We also thank Kathleen Vrankx, bioinformatics products 
specialist at Applied Maths, Belgium, for her statistical expertise and data analysis. 
 
  
   
  
3 
Abstract 
The human gut microbiota (GM) has shown to be engaged with the host immune system, 
thus having an impact on a broad range of diseases. GM can be manipulated by probiotics 
and thus influence the balance of the immune system. Evidence suggests that the GM is 
inherited from mother to offspring. Change in GM by probiotics and the inheritance from 
mother to offspring are investigated in mice models in our project. 
 
Methods: A litter of 10 BALB/cJ dams were given either 1-4*109 CFU/day of probiotics 
or PBS on a cheerio throughout pregnancy until day 21 days after birth. Faecal samples 
were collected from mothers at day 21 and pups at day 27. The QIAamp Fast DNA stool 
mini kit was used to extract bacterial DNA. Using primer HDA1 and HDA2 a PCR 
amplification of region V3 and V4 of the 16S rDNA gene were performed. DGGE was 
conducted to reveal the bacterial diversity in the samples. Band intensities and the 
differences between the bands were tested for statistical significance in BioNumerics 
Version 7.5.  
 
Results: No significant relationship between the mothers and their pups in either group 
was found in the PCA analysis. In the discriminant analysis, distinction between 
microbiotas from mothers and pups was clear, but there were no distinctions between 
mothers given probiotics and mothers given PBS.  
However, we did find two bands that were group-specific within the group of pups, but 
this difference is too small to indicate any large biological relevance. 
 
Conclusion: Based on our results, the probiotics do not change the GM in the mother 
mice and therefore no inheritance was observed. However, further analysis of the two 
deviating bands could reveal if it were probiotics or an effect of the probiotics. This could 
possibly be an indication of inheritance.   
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This project is written to bachelor students in 3rd year of medical biology and molecular 
biology and is built up around a theory section, which gives the reader a basic 
understanding of the scientific elements such as the GM, probiotics and mice model. The 
project is based on an experiment and the detailed protocols are placed in appendix 3.   
 
Literature search 
We made a PubMed and SUMMON search on the following search terms: “Gut 
microbiota”, “Microbiome”, “Animal models”, Immune cells”, “Probiotics”, “Faecal”, 
“DGGE”, “PCA”, “Inheritance”, “Lung microbiota” and combinations of these. Both 
Danish and English-language articles were included. Articles were selected based on their 
scientific and clinical relevance including both primary articles and reviews. Based on 
references in relevant reviews, we have tried to retrieve primary articles. Furthermore, we 
used Google Scholar, if the primary search machines were insufficient. 
 
 
Abbreviation  
16S rDNA: 16 subunit ribosomal DNA 
ANOVA: Analysis of variance  
CFU: Colony forming units 
DCs: Dendritic cells  
DGGE: Denaturing gradient gel electrophoresis 
FTM: Faecal microbiota transplant  
GI: Gastrointestinal tract 
GM: Gut microbiota 
HLA/TLR: Human leukocyte antigen/Toll-like receptor  
IEC: Intestinal epithelial cells 
IL: Interleukin  
LAB: Lactic acid bacteria  
LM: Lung microbiota 
MAMPs: Microbial-associated molecular patterns  
OVA: Ovalbumin  
PAMPs: Pathogen associated molecular patterns 
PBS: phosphate buffered saline  
PCA: Principal component analysis  
PCR: Polymerase chain reaction 
PRRs: Pattern-recognition receptors  
Tregs: Regulatory T cells  
UPGMA: Unweighted Pair Group Method with Arithmetic Mean 
APS: Ammonium persulphate 
TEMED: Tetramethylethylenediamine  
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1 Introduction 
In recent years the interest in the human gut microbiota (GM) has increased owing to its 
association with a broad range of diseases, ranging from metabolic disorders to 
autoimmune diseases, cancer, and neurodevelopment disorders (Guinane & Cotter, 2013; 
Nguyen, Vieira-Silva, Liston, & Raes, 2015).  
The GM is established when microbes colonize intestinal habitats after birth. These 
microbes are suggested to be inherited, since the microbial communities in the newborn 
closely resembles those found in the mother (Dominguez-bello, Costello, Contreras, 
Magris, & Hidalgo, 2010). Within days after birth the adult GM begins to form, ending 
up harbouring a complex community of up to 100 trillion bacteria, representing between 
500 and 1000 different species (Turnbaugh et al., 2007). These bacteria influence 
metabolism, nutrition, and immune functions in the human body (Foxx-Orenstein & 
Chey, 2012). When the microbiota is disrupted due to factors like diet, antibiotics, and 
hygiene the cooperation and functional stability between the GM and the host become 
imbalanced leading to dysbiosis. This imbalance can be compensated for by ingestion of 
probiotics, which confer health benefits for the host (Bengmark, 1998; Dongarrà et al., 
2013; Maranduba et al., 2015). These benefits include; decreased adhesion of pathogens 
to the epithelium, decreased colonization of pathogens in the host, and regulation of 
immune cells (Bengmark, 1998). 
The most frequently probiotics used are the Lactobacillus and Bifidobacterium species, 
which can be given as dietary supplements as tablets, capsules or powders, and as 
fermented dairy like milk and yogurt (Kligler & Cohrssen, 2008). 
In regards to this, our bachelor project’s aim is to investigate if probiotics alter the 
microbiota composition in mice and if this potential change is inherited from mother to 
offspring. 
Therefore, this study intends to answer the following:  
Does Probiotic treatment change the gut microbiota of the dams and if this potential 
change is inherited by their offspring? 
 
We expect to observe a change in GM composition of the dams after exposure to 
probiotics, thus an inheritance of this change to their offspring.  
 
The focus area of this bachelor project is a part of a larger ongoing study investigating the 
correlation between the composition of the lung microbiota (LM) after orally 
administered probiotics and the development of asthma. Our experimental setup is 
derived from this project, which will be elaborated in the theory section titled “The lung 
microbiome study”. 
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2 The lung microbiome study 
A study initiated in 2012 by Barfod et al. investigates the LM and the effect of probiotics 
on the development of asthma. This study was motivated by an observed increase in the 
development of asthma in western countries. The study investigates a possible correlation 
between LM and GM. Alterations in the GM affect the systemic immune defence, which 
might influence how the immune defence react to the bacteria in the lungs.  
The experimental design includes 100 mice regardless of gender and age, where the dams 
were exposed to probiotic and PBS. Additionally they injected these mice with ovalbumin 
(OVA) and Alum to artificially mimic asthma. This is necessary since mice do not 
naturally develop asthma (Nials & Uddin, 2008). The aim of the experiment was to see if 
the probiotic could alter the GM composition, which would influence the LM and thereby 
avoid or reduce asthmatic inflammation. The reduction was confirmed by observing an 
increase in immune cells. Factors like age, sex and inheritance of the GM are included in 
this study. A more detailed description of the project can be found in appendix 1. 
Our study is a smaller part of the lung microbiome study; see highlighted areas in figure 
1. We investigate 20 female mice in total: 10 mothers and their respectively 10 pups. The 
naïve pups were not injected with OVA, but sterile saline as they serve as an allergy 
control. The only treatment the dams received was probiotics or PBS administered orally, 
for more detailed information see the experimental section. 
This is a minor but essential part of this lung microbiome study, as we are looking at the 
possible alterations in the composition of GM by the probiotics and if these alterations are 
inherited from their mother. 
	  
Figure 1 shows the lung microbiome study where mice were treated with probiotic, PBS, and OVA. In scheme 
we have marked the specific mice used in our experiment. The purple highlights the mothers given PBS; the red 
highlights the mothers given probiotics; the green highlights the pups given PBS; the yellow highlights the pups 
given probiotics.  
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3 Theory 
In order to answer our problem formulation, knowledge about the gut microbiota, 
probiotics, and mice models are necessary. This knowledge will be used when discussing 
our results.   
3.1 Gut microbiota 
The human GM is estimated to consist of over a 1000 different bacterial species that 
counts ~1014 bacterial cells (Inoue & Shimojo, 2014). Symbiosis is defined as interactions 
between two different organisms that coexist in a complex ecological community 
constantly influencing each other. This can include both mutualism and commensalism. 
Mutualism is defined, as a relationship where both members benefit from the coexistence, 
whereas commensalism is when one member of the relationship benefits without helping 
or harming the other. The word “commensal” originates from Latin commēnsālis 
meaning, “eating from the same table”. As different strains of bacteria coexist in the 
human body and utilize the same nutrients as the host, this relationship is consistent with 
the definition commensal. When the host benefits from these bacteria, as it is in most 
cases, the relationship becomes mutualistic rather than commensalistic (Nicholson et al., 
2012).  
 
Gut microbes are generally harmless or beneficial to the host. One of the beneficial 
effects of Bifidobacterium is the protection against enteropathogens (Fukuda et al., 2011). 
Another strain of bacteria, shown to have a beneficial effect is the food related lactic acid 
bacteria (LAB), which has ability to supply vitamin B12. Besides the mentioned beneficial 
effects of the GM, it has been shown that the intestinal microbiota is involved in food 
digestion and energy recovery (LeBlanc et al., 2013). 
During the last decades the list of beneficial effects of GM has grown and so has the 
amount of GM associated diseases such as obesity, inflammatory bowel disease, 
neurological disorders, and cancer (Dicksved et al., 2008; Gonzalez et al., 2011; Ley et 
al., 2006; Lupton, 2004).  
The balance in damaged GM can be restored with a faecal microbiota transplant (FMT). 
This practice has gained ground in the last decade as an alternative to administering 
antibiotics (Rohlke & Stollman, 2012). Broad-spectrum antibiotics effectively eradicate 
commensal microbes, leaving more space for the pathogenic species to colonize. In an 
imbalanced diet free of polysaccharides like starch, cellulose, and xylans, the commensal 
bacteria cannot harvest energy. Therefore they cannot generate short fatty acids, which 
are toxic to some pathogens and can result in low intestinal epithelial barrier integrity 
(Geuking, Köller, Rupp, & McCoy, 2014). When the barrier is weakened, pathogenic 
bacteria can penetrate more easily and invade the human body (Fukuda et al., 2011). 
These few examples of beneficial and disease causing effects, of the GM, indicate 
interactions with host metabolism, nutrition, and immune function. 
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Prenatal influences 
The current paradigm states that the environment within the uterus and the fetus in the 
amniotic sac are considered sterile until the sac ruptures during birth (Dominguez-bello et 
al., 2010). However, studies show that the intrauterine environment contains bacteria and 
suggests that these bacteria influence and colonize the GM of the fetus before birth 
(Jiménez et al., 2005, 2008). The bacteria found to colonize the intrauterine environment 
includes Escherichia coli, Enterococcues faecium and Staphylococcus epidermidis, which 
also are found in the meconium, see figure 2. The presence of these bacteria species in the 
meconium is suggested to be a result of translocation of the mother’s GM through the 
bloodstream (Jiménez et al., 2008). This translocation was already confirmed by a study 
by Jiménez et al. showing that Enterococcus, Streptococcus, Staphylococcus, and 
Propionibacterium species are found in the blood of the umbilical cord (Jiménez et al., 
2005). Furthermore, DNA from Lactobacillus and Bifidobacterium are detected in the 
placenta at both cesarean section and vaginally deliveries, suggesting a horizontal transfer 
of bacterial DNA (Satokari, Grönroos, Laitinen, Salminen, & Isolauri, 2009). Whether 
colonization of the fetus’ GM begins with a prenatal growth is still debated and more 
research is needed to confirm this potential. An argument against prenatal colonization is 
the harvest of meconium, which is delayed up to several days after birth. In this period the 
mother’s microbiota from either vagina or skin can be transferred to the newborn’s gut 
(Matamoros, Gras-Leguen, Le Vacon, Potel, & De La Cochetiere, 2013).   
Figure 2 shows the impact of factors on the microbial composition from prenatal development to 
adulthood. The blue arrows indicate where in the lifecycle the different factors influence the 
microbiota. The green arrows indicate growth of beneficial bacteria. The red arrows indicate 
growth of disadvantageous bacteria. (Matamoros et al., 2013) 
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Development of the intestinal microbiota  
The primary colonizers in the gastrointestinal (GI) tract of the newborns are facultative 
anaerobic bacteria such as E.coli and other Enterobacteriaceae (Jiménez et al., 2008). 
These bacteria decrease the oxygen concentration to allow colonization by anaerobic 
microorganisms such as Bifidobacterium, Clostridium, Bacteroides, and Ruminococcus 
(Berg, 1996; Sommer & Bäckhed, 2013). The most dominant bacterial genus in the 
newborn GM is the Bifidobacterium including the most prevalent: Bifidobacterium breve, 
Bifidobacterium longum, Bifidobacterium adolescentis, Bifidobacterium 
pseudocatenulatum, Bifidobacterium bifidum, and Bifidobacterium dentium, see figure 3 
p. 11 (Aires, Thouverez, Allano, & Butel, 2011). The Bifidobacterium species utilize the 
oligosaccharides from the breast milk along with intestinal mucins and therefore naturally 
reside in the newborn GI tract to develop the microbiota. A new microbial composition is 
introduced when solid foods replace, and for example antimicrobial treatment interrupt, 
the supply of oligosaccharides and microbes from the mother (Salminen & Isolauri, 
2006). The low diversity and density of the intestinal microbiota of the newborn will 
develop and mature to an adult microbiota in approximately three years (Lozupone, 
Stomabaugh, Gordon, Jansson, & Knight, 2012). Only a small amount of the originally 
microbes will permanently colonize and contribute to the distinctive microbiota harbored 
by the human body (Berg, 1996; Sommer & Bäckhed, 2013). 
In the adult intestinal tract, microbial density increases from the proximal to the distal gut, 
with the stomach containing 10 cells per gram of content to the large intestine with 1012 
cells per gram of content, see figure 3 p. 11. The small density in the stomach and the 
upper two thirds of the small intestine are due to low pH of the stomach content, the 
peristalsis movements and bile salts (Berg, 1996).   
In the large intestine there are several factors that allow bacterial proliferation. These 
factors include less acidic environment, lower concentrations of bile salts, larger volume, 
and longer retention time due to slower peristalsis (Walter & Ley, 2011). 
The microbial diversity increases in the same manner as microbial density, ending up 
with about 500 species in the large intestine including the most abundant phyla; 
Firmicutes and Bacteriodetes. Other species include members of the phyla 
Proteobacteria, Verrumicrobiota, Cyanobacteria and Actinobacteria (Berg, 1996; 
Sommer & Bäckhed, 2013). 
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The microbiota in relation to the immune system 
The composition of the GM is affected by both environmental factors and a number of 
host genetic factors such as those influencing mucosal immunity. The immune system 
development largely finds its hold by being exposed to microbes colonizing neonate’s 
intestines, thereby modelling the immune response. 
The host’s immune system have shown to be engaged in a dynamic symbiosis with the 
complex community of diverse bacteria in the human GI tract where energy and 
metabolites are suggested to be exchanged (Cerf-Bensussan & Gaboriau-Routhiau, 2010). 
The most frequent bacteria in the gut are the commensals, which competes with other 
potential pathogenic microbes. It is therefore necessary for the immune system to 
discriminate between pathogenic bacteria that require a protective immune response to 
prevent inflammation and invasion; and the non-pathogenic microbiota or food antigens 
where a dynamic unresponsive state is required (Maranduba et al., 2015).  
 
When commensal bacteria are in balance the microbial-associated molecular patterns 
(MAMPs) and pattern-recognition receptors (PRRs) in the immune system start a 
cascade. This cascade stimulates intestinal epithelial cells to secrete molecules, which 
protect the epithelium and produce and maintain an anti-inflammatory and tolerogenic 
environment, see figure 4. In this state the immune system does not respond to substances 
or tissues that have the capacity to elicit an immune response (Cerf-Bensussan & 
Gaboriau-Routhiau, 2010). The development of IgA-producing cells also plays a role in 
symbiosis by preventing the binding of commensal bacteria on host epithelium. In this 
cascade, secretory IgA molecules form and create immune complexes with bacteria that 
retains in the mucus and maintain an anti-inflammatory environment (Cerf-Bensussan & 
Gaboriau-Routhiau, 2010; Kato, Kawamoto, Maruya, & Fagarasan, 2014; Tsuji et al., 
2008). IgA is able to prevent the binding of commensal bacteria to the host epithelium 
and thereby control the growth of commensal bacteria.  
Figure 3 shows the amount of different bacterial species 
scattered throughout the gastrointestinal tract (Berg, 
1996).  
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Due to this it is suggested that the IgA secreting cells are involved in the maintenance of 
microbial homeostasis and contribute in shaping the normal microbial community 
(Geuking et al., 2014; Tsuji et al., 2008). Commensal bacteria are usually restricted to 
serosa and do seldom travel further than the mesenteric lymph nodes. In Prayer’s patches 
the mucosal immune system, releases activated T-cells and B-cells, which secrete IgA, 
hereby limiting the penetration of commensal bacteria. This is thought to be a local 
immune response since the systemic immune defence is unaware of, and not affected by, 
commensal bacteria. Moreover, the innate immune system is able to destroy the few 
bacteria which crossover the intestinal wall (Macpherson & Harris, 2004). 
 
The anti-inflammatory environment can be disrupted, when an imbalance between 
commensal bacterial occurs (dysbiosis), thereby allowing pathogenic strains to colonize. 
Dysbiosis may result from lifestyle changes or medical practices for example stress, 
allergies, diet, hygiene, smoking, antibiotics, and vaccines. These factors promote the 
onset of gut inflammation by affecting the immune balance and/or the GM (Drossman, 
1996; Mayer, 2010). During dysbiosis immune reaction diseases can occur due to an 
immune cascade, where a pro-inflammatory environment is created, see figure 4. In this 
environment pro-inflammatory cells are not kept under control by tolerogenic dendritic 
cells (DCs), T regulatory cells (Tregs) and macrophages, which leads to non-specific 
stimulation and activation of destructive pro-inflammatory molecules (MacDermott, 
1996). 
 
  
Figure 4 shows that symbiosis and dysbiosis depend on the balance between commensal and 
pathogenic bacteria. Dysbioses result in production of an pro-inflammatory enviornment, 
where symbioses result in an anti-inflammatory environment (own production).  
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Extrinsic influences on the microbiota 
During birth, nursing, and early breastfeeding the mother represent the most influential 
external factor for the development of the newborn’s microbiome. The mode of delivery 
has a strong influence on the early gut colonization leading to different GM compositions 
(Dominguez-bello et al., 2010). Analysis of the meconium showed that if the newborn 
were vaginally delivered, the first gut microbial communities resembled the mother’s 
vagina, with the bacteria Lactobacillus and Prevotella. If the newborn were delivered by 
caesarean the GM would resemble the mother’s skin, dominated by Staphylococcus, 
Corynebacterium, and Propionibacterium, see figure 2, p. 9 (Dominguez-bello et al., 
2010). Furthermore, analysis of faecal samples collected three days after birth showed 
that colonization rates and bacterial counts of Bifidobacterium and Lactobacillus species 
were lower in newborns delivered by caesarean section than vaginal delivered (Grönlund, 
Lehtonen, Eerola, & Kero, 1999). The study by Grönlund et al. also showed that the 
primary GM in newborn delivered by caesarean section might be out of balance for up to 
six months after birth (Grönlund et al., 1999). 
Another factor that influences the development of the GM in newborns is the mode of 
feeding. A study by Collado et al. showed that the predominated species in breast milk 
are Staphylococcus, Streptococcus, Bifidobacterium, and Lactobacillus, which correspond 
to primary colonizers of the gut, see figure 2, p. 9 (Collado, Delgado, Maldonado, & 
Rodríguez, 2009). The fact that Bifidobacterium and Lactobacillus are detected indicate 
the importance of breast milk as a delivering system for probiotic bacteria (Fernández et 
al., 2013). Higher concentrations of Bifidobacteria and Lactobacillus and lower 
concentrations of Bacteroides, Clostridium coccoides, Staphylococcus, and 
Enterobacteriaceae are found in breastfed newborns compared to newborns that are 
formula-fed (Fallani et al., 2010; Harmsen et al., 2000). 
The bacteria Lactobacillus, Staphylococcus, and Bifidobacterium found in the breast milk 
of mothers have shown to be identical with their newborns faecal, suggesting 
breastfeeding as a source of early gut colonization in newborns (Martin et al., 2012). 
Breastfeeding have other beneficial effects; it contribute to reduction of infections in the 
newborn by different mechanisms like production of antimicrobial molecules and 
improvement of the intestinal barrier (Olivares, Díaz-Ropero, Martín, Rodríguez, & Xaus, 
2006).  
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3.2 Probiotics 
The GM can be manipulated by the use of probiotics, which were demonstrated by the 
properties of lactic acid bacteria in 1909 and the discovery of the influence of diet on the 
composition of the microbiota (Kendall, 1911).  
The first probiotic product intended to cure intestinal problems such as infectious diarrhea 
was Mutaflor®. It was discovered during World War I where stool samples from soldiers 
were screened in order to find a strain that functioned as an antagonistic against 
Salmonella and Shigella. In 1917 Alfred Nissle found a strain that exhibited these 
properties, and called it “E. coli Nissle 1917”. Since 1917, “E. coli Nissle 1917” has been 
used against infectious diarrhea, non-infectious GI disturbances and diseases, chronic 
constipation, and inflammatory bowel diseases. 
“E. coli Nissle 1917” is still found in Mutaflor®, used to treat various diseases and 
dysfunctions of the intestinal tract (Dalziel et al., 2015).  
 
The GM composition can be regulated and controlled with probiotics, which are living 
microorganisms. When administrated in adequate amounts they confer a health benefit for 
the host (FAO & WHO, 2002). This health benefit includes decrease in both adhesion of 
pathogens to the epithelium, regulation of the immune cells, and decrease colonization of 
the pathogens in GM (Bengmark, 1998; Doron & Gorbach, 2006).  
Prebiotics are food supplements that are generally non-digestible and can be given to 
stimulate the growth and/or activity of probiotic bacteria (Gupta & Garg, 2009). 
The effects of probiotics are strain specific and therefore even closely related probiotic 
strains may have different clinical effects (Alvarez-Olmos & Oberhelman, 2001; 
Bengmark, 1998). The most frequently non-pathogenic bacteria are LAB and 
Bifidobacterium species, but also yeast like Saccharomyces boularidii may have benefits 
regarding to the hosts health (Bengmark, 1998; Williams, 2010). The S. boularidii have 
shown to degrade Clostridium difficile toxins A and B and their intestinal receptors in 
human colonic mucosa (Castagliuolo et al., 1999; Castagliuolo, Mont, & Nikulasson, 
1996).  
LAB species produce lactic acid, acetic acid, and propionic acid. These acids supress the 
growth of pathogenic bacteria by lowering the pH value in the intestinal tract and thereby 
re-establish the balance of GM. They also produce hydrogen peroxide, which change the 
environment from aerobic to anaerobic and thereby inhibits bacterial growth (Doron & 
Gorbach, 2006; Williams, 2010). Furthermore, LABs strengthen the barrier of the 
intestinal mucosa by stabilizing tight-junctions (Otte & Podolsky, 2004). Bifidobacterium 
are important in regards to the development of the newborn’s mucosal immune system 
and microbiota, where it becomes dominant after birth until the weaning period 
(Salminen & Isolauri, 2006). 
Both LAB and Bifidobacterium species have shown to influence both the innate and the 
adaptive immune responses (Borchers, Selmi, Meyers, Keen, & Gershwin, 2009; 
Dongarrà et al., 2013; Lee & Salminen, 1995). One way they exhibit their activity is by 
binding to PRR expressed on immune cells and intestinal epithelial cells (IECs).  
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PRR recognise PAMPs and send signals to induce the production of cytokines and 
activates antigen presenting cells. More precisely will different combinations of PAMPs 
expressed by different types of probiotics be recognized by the PRR on DCs and thereby 
induce a cytokine release (Dongarrà et al., 2013). 
Depending on the probiotic and cytokine released, the cytokine will produce a signal 
through human leukocyte antigen/toll-like receptor (HLA/TLR) complexes for naive T 
cells to differentiate into Th1, Th2 or Th17 cells, see figure 5 (Dongarrà et al., 2013).  
In this pathway, probiotics have shown to influence DC maturation, cytokine 
secretion, and T cell differentiation, which have shown beneficial in some diseases 
(Borchers et al., 2009). An example could be Th1-mediated diseases, where the 
ability to inhibit IL-12 production, which produces Th1 cells, through the release 
of L. reuteri and B. bifidum could restore the gut immune system homeostasis 
(Borchers et al., 2009). Besides the immune modulation, probiotics have shown to 
induce regulatory Treg cells, increase the local IgA production, and up-regulate IL-
10, which has an anti-inflammatory and tolerogenic effect (Klaenhammer, 
Kleerebezem, Kopp, & Rescigno, 2012).   
 
 
 
 
Figure 5 shows that distinctive commensal bacteria can trigger different 
adaptive immune responses. Through the pattern recognition receptors 
on the dendritic cells divergent cytokine is released and will produce a 
signal, which will result in differentiation of T-cells into either Th1. Th2 
or Th17 cells (Dongarrà et al., 2013). 
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The efficacy of the probiotics depends on their ability to survive the passage through the 
GI tract and their ability to colonize tissue. The probiotics can be coated or 
microencapsulated to prevent destruction by gastric acid and bile salts. This coating also 
stabilises the probiotics when they pass through the GI tract (Kailasapathy, 2002).  
Probiotic colonization on the surface of human IECs can occur when probiotics are 
ingested in the right concentrations on a regular basis. The recommended daily dosage of 
Lactobacillius and Bifidiobacterium species ranges from 108 to 35*109 colony-forming 
units (CFU) per day. This depends on the brand and the drug preparations such as 
capsules, powder or therapeutic yogurts and fermented milks. More specific, the dosage 
range from 5*109 to 1010 CFUs per day for children and from 1010 to 2*1010 CFUs per 
day for adults. The recommended daily dosage for S. boulardii lies between 250 mg to 
500 mg in capsules (Gupta & Garg, 2009; Kligler & Cohrssen, 2008). Beside the 
concentration, the lifespans of the probiotics should be considered. For example the 
species L. acidophilus and B. bifidum both have a short lifespan, demonstrated by a short 
stationary growth phase, followed by a rapid loss in cell viability (Lee & Salminen, 
1995).
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3.3 Mice models 
The ethical considerations have been the main cause for not allowing human as model 
organisms (Sierra, 2011). Therefore model organisms have been widely used in 
experimental studies for centuries and it has helped researchers to understand the 
biochemical processes, physiological systems and human diseases. The list of model 
organisms has been long and ranged from bacteria to mammalian animals during the 
history of medical science (Müller & Grossniklaus, 2010).  
The primary model used in genetic and biomedical research is the mice model. The mice 
and human have anatomical and physiological structural similarities and 99 % gene 
homologs (Griffinths, Wessler, Carrol, & Doebley, 2012; Nguyen et al., 2015). 
Advantages of using mice models are their ability to reproduce every 10 weeks, easy 
maintenance due to their small size, low cost and their short life cycle. Because of these 
advantages mice have been the preferred animal used as model for research in the 
immune, - endocrine, - nervous, and cardiovascular systems (Nguyen et al., 2015). These 
systems can be genetically and/or environmentally manipulated to mimic human diseases 
like asthma (Russell et al., 2012). 
 
Inbred mice 
Inbred mice are the most frequently used animal model in experiments due to greater 
homogeneity. They are identical in their genotype due to a long line of inbreeding 
(Casellas, 2011). Outbred strains describe genetically different mice from non-sibling 
mating. On Contrary, inbred mice are used, since they are known to have higher 
similarity in the GM than outbred mice. Even so, GM in the same strain differs between 
colonies from different firms (Hufeldt et al., 2010; Vaahtovuo et al., 2003). The inbred 
strains are genetically defined and outbred strains are genetically undefined and can be 
used to describe the main difference between the two forms of breeding (Chia, Achilli, 
Festing, & Fisher, 2005). 
There are two basic requirements to define a strain as inbred. First, the strains must derive 
from a single breeding pair of individuals in the 20th or later generation. Second, 20 or 
more consecutive generations of full sibling mating should be accomplished (Staats & 
Harbor, 1976). Thereby a minimum level of approximately 98,6 % genetic similarity and 
maximum 2% of genetic variance in the base generation is assured (Casellas, 2011; M. F. 
W. Festing, 1981). The long inbreeding results in more stable and uniform strains 
(Casellas, 2011). The first inbred mouse strain was created by C.C Little in 1909 
(Casellas, 2011). A/J, C3H, C57BL/6, CBA, and BALB/c are among the most commonly 
used strains and were developed in the early 1920s (Staats & Harbor, 1976). These inbred 
strains of mice have contributed to the development of new inbred strains (Casellas, 
2011). The most commonly used strain in immunological research is the inbred strain 
BALB/cJ due to their sensitivity for allergens. They produce allergy markers as IgE and 
IgG1 antibodies as a response for the OVA induction (Chen et al., 2013). BALB/cJ 
mouse has 99% homozygosity and are characterized by its white colour. The generation 
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of BALB/cJ mice have reached 235 in 2005 according to Jackson Laboratories, which 
assures that the mice are not genetic different (M. Festing, 1998). 
 
 
Mice models limitations 
Despite the important similarities listed, mice and human have anatomical, genetic, and 
physiological differences. Therefore mouse models will not fully review human systems. 
One example is the differences in the GI. Humans and mice share the same organs in the 
GI and the average ratio of the intestinal surface are similar, but the ratio differs over 
different sections of the gut (Casteleyn et al., 2010). Moreover, the microscopic structure 
of the intestinal tract and the distribution of paneth -and goblet cells between the two 
species differ (M. Treuting, A. Valasek, & M. Dinitis, 2012).  
It has been shown that humans and mice GM are different in both composition and 
bacterial genera; 85 % of bacterial genera found in healthy mice are not present in a 
healthy adult human (Backhed, Ley, Sonnenburg, Peterson, & Gordon, 2005).  
 
In an experimental setup it is important to avoid variables. By excluding variables, the 
baseline for comparison will be strengthened and the obtained samples can be used for 
further examinations. Variables could be drinking water, living conditions, or the diet, 
which should be the same for each group. The handling of mice should also be considered 
throughout the experiment, thereby stress can be excluded as a factor (Nguyen et al., 
2015). By placing the mice in cages, where the access for external microbes, are strictly 
regulated, the contamination by pathogens that can have an impact on the GM, are 
avoided as much as possible (Jacoby & Lindsey, 1998). External microbes can also be 
passed from the animal keepers to the mice. Mice can be kept in specific-germ-free (SPS) 
facilities that are designed to be clean and strictly controlled for pathogens (Nguyen et al., 
2015).  
  
   
  
19 
4 Methods 
A flowchart is presented to give an overview of the experiment and the analysis of the 
obtained data, see figure 6. The flowchart illustrates the experimental work performed by 
us and technicians. On the next pages a detailed description of the experimental setup and 
work are explained. The exact procedures can be found in appendix 3. 
 
In this experiment a mice model was applied to investigate the effects of probiotic 
treatment on the GM and the possibility of inheritance. In the experiment faecal samples 
were collected from mice given a combination of two probiotics, a control group, and the 
pups from both groups.  
The mice in our study were kept in laboratories in National Research Center For Working 
Environment (NRCWE) and the experiments were conducted in laboratories at the 
NRCWE and Statens Serum Institut (SSI).  
Stool samples were collected by technicians and provided to us by our supervisor, 
therefore no unauthorised interaction have occurred with the mice.  
After collection a DNA extraction, a polymerase chain reaction (PCR) and denaturing 
gradient gel electrophoresis (DGGE) were conducted, to see if any differences between 
the mothers and the pups were observed.  
The primers for the PCR were designed to match the variable regions V3 and V4 of the 
16S rDNA gene. The amplified DNA from the PCR was used to conduct a DGGE. This 
would reveal differences between GM compositions of the probiotic treated mothers and 
the control group.  
Statistical analysis was performed by Kathleen Vrankx from Applied Math, Belgium 
using BioNumerics Version 7.5. The results are presented in “Data processing and 
analysis”.  
 
Experi-­‐mental	  setup	   Sample	  collcetion	   DNA	  extraction	   PCR	  ampli9ication	   DGGE	   Visuel	  analysis	   Statistical	  analysis	  
Figure 6 shows the processes and procedures of the experiment and following work with the collected data. The grey boxes 
represent work conducted by technicians and the blue boxes represents procedures we performed (own production). 
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5 The mice experiment 
The subset experiment was conducted with 20 female mice in total; 10 of them were 
mothers and 10 were their respective pups. The mice were BALB/cJ from Taconic M&B, 
Ry, Denmark and were reared together. The 10 female mice were 7 weeks old, and had a 
weight around 18-22g. In groups of two, the female mice were mated with one 10 weeks 
old male for 3 days, see figure 7. After mating the two females were randomly distributed 
into two groups, one receiving probiotics on a cherrio. Both groups were housed in cages 
(425×266×150 mm). The mice were fed ad libitum with tap water and special pregnancy 
food Altromin from Brogaard Denmark (no. 1324). Altromin were given to dams for 
optimizing their nutritional needs. The mice were kept in the cages with light/dark cycles 
of 12 hours and temperature conditions at 19-22 ºC with 40-60% humidity.  
The mice were handled by the same technicians and the protocol was approved by the 
Danish Animal Experiments Inspectorate (LBK 1306 of 11.21.2007). The animals had 
two weeks to acclimatise in the animal facilities before mating. All experiments were in 
accordance with Council of Europe Convention European Treaty series 123.  
 
The probiotics used were L. acidophilus NCFM (ATCC 700396) and B. animalis ssp. 
lactis Bl-04 (ATCC SD5219) from DuPont Nutrition & Health, Finland. A study by 
Forsythe showed that these bacterial strains inhibited respiratory tract infection and this 
mixture of probiotic have been widely and extensively used in animal models and for 
clinical purposes (Forsythe, 2011). Another study by Ouwehand et al. showed that these 
probiotics had beneficial effects on the human immune defence (Ouwehand et al., 2009).  
 
The mice experiment ran for 42 days for mothers and 46 days for pups from mating to 
termination. 
 
 
	  
 
 
 
 
Figure 7 shows an overview by a timeline over our experiment. The mice are mated for three days 
preceded by 2 weeks of acclimatization to the stables. The mice conceive on day -21. The pregnancy lasted 
for 21 days, day -21 up to day 0. On day 0 the pups were born vaginally and stayed in the cage with their 
mothers. The pups suckled up until day 10, where they were weaned afterwards. On day 21 the faecal 
samples of the mothers were collected and the mothers were terminated. The samples from the pups were 
collected at day 25 where they were terminated. 
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On day 21 the mothers were separated from their pups, the faecal samples were collected, 
and the mothers were killed, see figure 7. 
The faecal samples from the pups were collected at day 25 and the pups were killed. 
 
 
 
We named the mothers: 1M, 2M, 3M, 4M, 5M, 6M, 7M, 8M, 9M and 10M, and pups 1 
U, 2U, 3U, 4U, 5U, 6U, 7U, 8U, 9U, and 10U, see figure 8. 
The number refers to mother and pups, which are related; for instance the mother to pup 
1U was 1M and the mother to pup 2U was 2M etc.  
The first group of dams (1M-5M) received probiotics from conception, during pregnancy 
and until they were killed. The second group of dams (6M-10M) were controls. The mice 
were fed with one Oats Cheerios Breakfast cereal, (Nestlé, Denmark), which was either 
soaked with 200 µl phosphate buffered saline (PBS) or 200 µl probiotic suspensions. The 
mice received approximately 1-4 x 109 CFU per day. The pups from the probiotics fed 
mothers were not exposed deliberately to probiotics.  
The faecal samples are snap frozen in liquid nitrogen and kept in a freezer at -80 ºC 
before use.  
  
Figure 8 shows the correlation between the mothers and their pups. 1M gave birth to 1U etc. 
Samples 1M-5M were given probiotics and 6M-10M were given PBS (own production).  
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5.1 DNA extraction 
The samples were taken out of the freezer for the DNA extraction from the faecal pellets.  
QIAamp Fast DNA stool mini kit was used to purify the bacterial DNA from the frozen 
stool samples. We followed a modified protocol that reduces the total time needed for 
samples to be isolated to approximately 25 minutes. 
The samples were suspended in InhibitEx buffer to neutralize the high amount of PCR 
inhibitors, which can suppress the PCR signals in the later process. The mix with faecal 
samples and InhibitEx buffer also contained zirconium beads and a steel ball to aid in the 
disruption of the faecal pellet. The bacteria cells from faecal pellets were disrupted at 30 
HZ for 6 minutes by the Tissue Lyser System (Qiagen).  
After disrupting, the supernatant was mixed with proteinase K and AL buffer and 
incubated for cell lysis. Afterwards the DNA in the lysate was bound to QIAamp silica 
membrane, which was washed to remove any remaining inhibitors and contaminants. The 
isolated intact DNA was then eluted from the membrane with elution buffer (ATE) and 
loaded into new tubes. For more detailed description see the protocol in appendix 3.1. 
5.2 PCR amplification 
After DNA purification the variable V3 and V4 region of the 16S rDNA gene was 
amplified (Barfod et al., 2013; Smith, Li, Andersen, Slotved, & Krogfelt, 2011). This was 
done using the universal primer sets HDA1, with a GC-clamp in the 5’ end, and HDA2 
purchased from MWG Biotech, Germany, see table 1. See appendix 5 for certificate of 
analysis  
 
Table 1 shows the forward and reverse primers used in this experiment. On the forward primer a G-C clamp is 
attached to the 5’-end.   
Forward primer 
(HDA1), position 
(338-357)  
(5´ACTCCACGGGAGGCAGCAGT´3) 
40 base-pair GC-
clamp of Forward 
primer  
(CGC CCG GGG CGC GCC CCG GGC 
GGG GCG GGGGCACGGGGG G). 
Reverse Primer 
(HDA2r) position 
539-561 
(5´GTA TTA CCG CGG CTG CTG 
GCA C´3) 
 
The PCR was conducted in a total volume of 50 µl; 40 µl MIX and 10 µl DNA template. 
The tube containing the 50 µl PCR mixture was amplified at 68°C and 95°C degrees. For 
further details see appendix 3.2. After the amplification the PCR products were stored in the 
freezer until next step.  
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5.3 DGGE 
The DGGE technique enables separation of the double stranded DNA fragments of the 
same or similar length by utilizing a denaturing gradient gel (Valaskova & Baldrian, 
2009). The polyacrylamide gel is exposed to a constant heat of 60 °C and contains an 
increasing concentration of denaturant, which is a mixture of urea and formamide. The 
negatively charged PCR products, are loaded on the gel and forced to migrate through the 
pores of polyacrylamide toward the attractive positive electrode (Fatoudiarrassoubaly, 
2007). A combination of heat and denaturants, forces the DNA molecules to unwind 
(Fatoudiarrassoubaly, 2007; Muyzer, 1999). The double stranded DNA fragment 
denatures when it reaches a specific position in the gradient, and the mobility of the 
fragment is rapidly decreased (Valaskova & Baldrian, 2009).  
Variations in the DNA sequences, allows the fragment to migrate and melt at different 
positions in the gel (Fatoudiarrassoubaly, 2007). A complete denaturation is prevented by 
adding a GC-clamp, which is a G-C rich sequence that does not melt, at the 5’ end of the 
forward primer used in PCR (Valaskova & Baldrian, 2009). This separation technique is 
therefore based on the electrical charge, shape and molecular weight of DNA fragment 
(Fatoudiarrassoubaly, 2007). 
The result of the DGGE analysis provides a gel, which is stained with GelRed to reveal 
the bands. Each band corresponds to a 16S rDNA amplified product from the bacterial 
strain. The intensities of the bands correspond to the frequency of each individual PCR 
product in the mixture (Valaskova & Baldrian, 2009). The bands are used to determine 
the similarity of the microbial communities (Peterson, 2007). The bands can be re-
amplified, and/or excised from the gel, purified and sequenced to determine the nucleic 
acid composition (Riemann & Winding, 2001). 
For further details of a DGGE see appendix 2. 
5.3.1 Preparing the gel 
Before the PCR product could be loaded, the stock solutions should be prepared, and the 
glass plates for casting the gel had to be assembled.  
The frames for the gels were assembled as follows; two glass plates, divided by a spacer, 
were mounted into the clamp and placed in the casting stand. This created a chamber 
within the plates, which was tested for leakage with Milli-Q water before casting the gel.  
In the meantime two solutions are prepared, a denaturing 0 % working solution and a 
denaturing 80 % working solution, see appendix 3.3. These solutions were stored at room 
temperature until use.  
When these preliminary preparations were performed the casting of the gel could begin.  
First, the low and the high gradient solutions were prepared, using the denaturing 0 % and 
80 % working solutions. The working solutions were mixed with 10 % ammonium 
persulphate (APS) and tetramethylethylenediamine (TEMED). The high gradient solution 
was also mixed with loading dye, see appendix 3.3. After mixing the two solutions they 
were poured into a high and low gradient marker, which were connected to a needle 
nozzle.  
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The chamber between the glass plates was carefully filled with gradients using the needle 
nozzle, see figure	  9. Afterwards, Milli-Q water was added to the top of the gel to avoid 
dehydration during the two hours of polymerization.  
After two hours the water was removed, a comb was inserted, and stacking gel was 
slowly added. After one-hour of polymerization the gels were ready to be loaded, see 
appendix 3.3 for further description.  
 
 
5.3.2 Running the gel 
The gels ran in a DGGE tank filled with seven litres of 1xTAE buffer. This buffer was 
preheated to 60 ºC. The clamped plates containing the gels were removed from the 
casting stand and placed in the cooling core.  
The PCR products, the markers, and the random DNA were prepared for loading by 
adding 5 µl 6x MassRuler DNA loading dye to 30 µl of the sample. The marker used 
contained 12 different bacterial strains isolated and amplified by PCR with HDA1-
/HDA2 primer set and were mixed with the PCR products before use. These mixes were 
loaded into their respective lanes in the DGGE gel, see appendix 3.3. After all sample 
were loaded into the gel, clamped plates with the cooling core, were inserted into the 
DGGE tank. The samples on the gels ran for 16 hours at 70 V. 
 
  
Figure	  9	  shows	  casting	  of	  the	  gel.	  In	  the	  picture	  the	  needle	  nozzle	  are	  used	  to	  
transfer	  the	  high	  and	  low	  gradient	  solutions	  into	  the	  chamber	  between	  the	  glass	  
plates	  (own	  production).	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5.3.4 Staining the gel 
GelRed staining solution was prepared according to manufacturer and 
the gels were stained for 30 minutes, see appendix 3.3. GelRed is a DNA 
dye with fluorescence abilities. After staining, the gels were transferred to 
an UV table and viewed under illumination. Pictures were taken and 
saved as TIEF images for further statistical analysis.  
5.3.5 Analysis of the data 
In order to understand the analytic tests chosen and performed by Kathleen Vrankx a 
theoretical introduction of the tests are described in this section. 
5.3.5.1 Principal Component Analysis (PCA) 
In our experiment we used this unsupervised analysis for visualising similarities between 
the samples in the DGGE. The analysis is used to reduce dimensionality of a data set. The 
data are transformed into a new set of variables, Principal Components. These are 
uncorrelated, but contain relevant information from the data. This analysis decompose 
data based on the highest variances in the data set and is used as a pre-processing step for 
further analysis, visualised as a PCA plot (Yao, Coquery, & Lê Cao, 2012).  
5.3.5.2 Discriminant analysis 
The discriminant analysis, which is a supervised analysis, was used in our experiment to 
analyse the bands on the DGGE gel. One band on the gel correspond to the DNA 
obtained from one bacteria species and can then be identified as belonging to a certain 
class, which have some character in common. The discriminant analysis is constructed 
based on our raw data and can be visualised as a 3D plot.  
Determining the most probable class for a species is done by a mathematical decision rule 
based on a set of discriminant functions belonging to each population, here variables 
should be observed to see if they are effective in predicting the class (Ottestad, 1975).   
5.3.5.3 Kruskal-Wallis test 
Kruskal-Wallis test is a non-parametric test that can be applied to variables measured on 
ordinal or interval scales when a one-way ANOVA test is not applicable. It compares the 
medians of three or more samples. In our experiment the Kruskal-Wallis test was applied 
to test differences in band intensities between all the four groups.  
First the data are ranked and then the null hypothesis is proposed. It states that the mean 
ranks of the two groups are the same. It can be used to test similarities within a group. A 
P >0.05 indicates that the null hypothesis cannot be rejected and that similarities are 
found within the different groups (Fowler, Cohen, & Jarvis, 1998; McDonald, 2014). 
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5.3.5.4 Mann-Whitney test 
Them Mann-Whitney test is a non-parametric test, which is used in our experiment to test 
two unpaired groups by comparing the medians of the two samples. This test is chosen 
when a t-test is not applicable because the data set consists of variables measured on 
ordinal or interval scale, because the values of the observations are converted to ranks. 
Furthermore it is distribution free, which makes it suitable for data that are not normally 
distributed (Fowler et al., 1998).  
5.3.5.5 Jackknife  
Identify small subset of data that influence the statistical measurements. It identifies 
outliers and bias in the statistics. The spread of individual values in a summary statistic 
can be examined. First, one observation is eliminated, and a new mean is calculated. Then 
the observation is included and a new observation is excluded and a mean is calculated. 
This is done for all the observations in the dataset. Lastly, the overall statistic mean is 
compared to the individual jackknifed means. This comparison give an idea of the 
influence of each value on the summarized value based on the difference between these 
means (Allen & Seaman, 2008). In our experiment we applied it to determine the 
separation between the groups, both between the four groups and between probiotic and 
PBS mice, and the mothers and pups. 
5.3.5.6 ANOVA 
A one-way ANOVA test is applied when a comparison between the means of two or 
more samples are necessary. ANOVA is used instead of performing several t-tests in a 
row. This increase the risk of misinterpretation of the results based on the level of 
significance because there is a 5 % risk of reaching a wrong conclusion for each t-test 
performed (Fowler et al., 1998).  
In our analysis we did a one-way ANOVA on numbers of bands in the different samples. 
The counting of bands was done manually.  
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6 Data processing and analysis 
Before processing the data from the DGGE experiment, the two gels were evaluated to 
see whether work in the lab had been consistent. In figure 10 the two DGGE gels are 
depicted. They show a clear DGGE, the marker lanes are necessary for precise 
discrimination by the data analysis software. Moreover, one contamination control was 
added to each run in order to evaluate the quality of the laboratory work. The “PCR” 
sample represents DNA fragments from the purification kit used and the lane marked 
“H2O” represents the handling of the amplified PCR products. Both these lanes show 
some weak bands, which indicate very little contamination.  
 
The outside lanes marked “DNA” were added for stability in order to reduce “frowning” 
of our samples in the gels under electrophoresis. The photographs were loaded into the 
data analysis software BioNumerics Version 7.5 (Applied Maths NV, Sint-Martens-
Latem, Belgium) for data processing. The actual data processing was done by an 
employee at Applied Math, Belgium.  
 
 
Prior to computable data processing, it was examined whether any visible difference 
between any of the four different groups could be observed. Via photo editing software, 
pictures for comparison were constructed, see figure 11. There was no obvious difference 
between probiotic treatments and PBS, see figure 11 p. 28. In the same way, there are no 
visible similarities between mothers and pups see figure 12 p. 28. 
Figure 10 shows the two photographed gels, where the samples were randomly distributed, representing all four groups on 
both gels. 
(a) Each 16S rDNA amplified sequence migrates to a specific position in the gel. The DNA denaturize in a sequence 
dependent manner. The outside lanes marked “DNA” were added for stability in order to reduce “frowning”. The lane  
marked PCR were added for contamination control of the PCR kit. 
(b) Each 16S rDNA amplified sequence migrates to a specific position in the gel. The DNA denaturize in a sequence 
dependent manner. The outside lanes marked “DNA” were added for stability in order to reduce “frowning”. The lane  
marked H2O were added for contamination control of performance. 
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Figure 11 shows a visual comparison of the effect of probiotic treatment between the two groups of mothers, as 
well as the effect in the pups. There is a small difference between mothers and the pups 
There was no obvious difference between probiotic treatments and PBS, see figure 11. In 
the same way, there are no visible similarities between mothers and pups see figure 12. 
 
	  
Figure 12 shows a visual comparison between the mother and her respective pup.  There are no visible 
similarities between mothers and pups.  
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Moreover, no comparison could be found when the number of bands was examined in 
figure 13 and figure 14. A simple single factor ANOVA test between mothers probiotic 
and mothers PBS shows that the null-hypothesis cannot be rejected, since the analysis 
showed a P value of 0.46, indicating that there is no significant difference in the means of 
the two groups, see appendix 4. The null-hypothesis is rejected when P>0.05. According 
to the project hypothesis, the study is trying to confirm a dependency, in a statistical sense 
though, it is assumed that the samples are from individual organisms and therefore 
independent of each other.   
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Figure 13 shows a diagram with the number of bands in each sample. There is no visible difference between the 
variations within the mother treated with probiotics and the mothers treated with PBS. Nor is there a visual 
difference between the groups of pups.    
Figure 14 shows a diagram with the number of bands in mothers and pups. There is no resemblance in the number 
of bands between the mother and her respective pup. 
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6.1 Clustering analysis of the DGGE patterns and PCA plot 
Using analytic tools in BioNumerics, a dendrogram was constructed setting the data as 
unsupervised with the UPGMA (Unweighted Pair Group Method with Arithmetic Mean) 
algorithm visualised as a dendrogram, see figure 15(a). A PCA plot was also constructed 
as a 3D visualization of the hierarchical clustering, see figure 15(b).  
 
	  
Figure 15 (a) shows a dendrogram based on our raw data samples. The samples are clustered into mothers and 
pups, except an outlier of the pups, “Pups probio”. 
(b) shows a PCA plot based on our raw data. Red dots: pups, probiotic; purple dots: pups, PBS; yellow dots: 
mothers, probiotic; green dots: Mothers, PBS. There is an indication of clustering between the mothers and 
pups. 
 
The dendrogram, based on the DGGE profiles of the 16S rDNA amplicons, shows a clear 
clustering of the mothers and the pups in separate groups. The clear clustering of the 
mothers versus the pups can also be found in the PCA analysis, see figure 15. The 
clustering analysis does not show a clear separation between PBS and probiotic treated 
mice. A pup treated with probiotics was located in the clusters representing the mothers. 
This particular sample is considered an outlier, see figure 15, 3U.  
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6.2 Discriminant analysis  
The discriminant analysis of the bands looks at the maximum and minimum variation 
within the defined groups; PBS treated mothers (purple), probiotic treated mothers (red), 
pups probiotics (yellow), and pups PBS (green). A separation of all the four groups can 
be seen in figure 16. This indicates that there are bands that are specific for each group. 
Although there is a separation between the four groups based upon the group-specific 
bands, the prevalent distinction is between mothers and pups. The probiotic treated 
groups are separated based on two bands.  
  
The band intensities and the differences between them were then tested. The Kruskal-
Wallis test was used to test for statistical differences between all four groups and the 
Mann-Whitney test used to test for statistical differences between the mothers and the 
pups, and PBS treated mice and probiotic treated mice, respectively. 
The group separation was determined with the Jackknife method, and the results are 
shown in table 2. The results indicate that there is a poor separation between the four 
groups, but that the mothers are well separated from the pups. Furthermore, the probiotic 
treated groups is not separated clearly from the PBS treated groups. 
 
 	  
Figure 16 shows the discriminant analysis visualised as a 3D plot. There is a clear 
clustering between the four groups. Red dots: mothers, probiotic; purple dots: 
mothers, PBS; yellow dots: pups, probiotic; green dots: pups, PBS. 
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The tests show no correlation of treatments within the two groups, probiotic or PBS, but it 
makes 100% discrimination between mothers and pups, represented by the zero values in 
table 2. Moreover, discrimination between mothers treated with probiotics and PBS 
respectively is not attained. According to data from the test there is a larger resemblance 
within the groups of mothers (mothers: probiotics and PBS) than within the group itself 
(PBS pups and mothers; probiotic treated pups and mothers). This also applies to the two 
groups of pups.  
Moreover, it should be mentioned that in the discriminant analysis there were three bands 
that distinguished between probiotic treatment and PBS although only two are to be found 
in all groups as well, see figure 17.  
 
Figure 17 shows the two deviating bands which discriminate between all four groups. A third band only discriminates 
between the PBS and probiotic but not between the mothers and pups.  
Table 2 shows the average recognition rates between paired groups. The PBS treated mothers are 60% similar 
to the probiotic treated mothers. And we see a 100 % discrimination between pups and mothers.  
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7 Discussion 
We chose to use DGGE in our experiment because it is a fast way of showing bacterial 
community changes and because we wanted to investigate probiotics influence on the GM 
diversity. In continuation to this we wanted to study if this change could be inherited from 
mother to offspring. We did not observe this in our analytical tests, because there were no 
significant differences in the GM between the mothers given probiotics and the control 
group, besides two bands that deviate in the DGGE gel, see figure 17. 
We had expected to observe some bands with higher intensity due to probiotics effect on 
bacterial composition. Probiotics could regulate the amount of bacteria thus affecting the 
intensity of the bands. The intensity of the band can also be affected by the number of 
bands placed at same position in the gel. Furthermore we expected a different distribution 
of bands in DGGE due to a higher diversity in probiotic treated mice. 
It could be suggested that probiotic only work if the immune system, thus the microbiota, 
is out of balance and this is why we do not observe a difference between the two groups. 
If we had observed differences in bacterial composition between mothers given probiotics 
versus mother given PBS, the probiotics could have had an impact on the immune 
balance, and thereby the intestinal homeostasis.  
If dysbiosis had occurred in the immune cells, due to factors like asthma, the imbalance in 
immune cells is not restored, if the GM is not altered. This can lead to a pro-inflammatory 
environment in the gut immune system.  
 
The probiotic did not alter the GM composition of the mother, thus we could neither 
expect nor observe any inheritance of changed composition due to the ingested probiotics. 
Since we could not observe any differences between the groups it is not possible to 
conclude if inheritance occurs.  
Factors that could explain these findings could be the probiotics used in our experiment. 
The probiotics, L. acidophilus and B.animalis lactis, were given to the mice based on 
their beneficial effects on the human immune defence system. The fact that these 
probiotics have been seen effective in the human GM does not necessarily mean they will 
have an optimal or GM changing effect in mice. This is partly due to basic differences in 
the human and mice guts as the bacterial composition differs 85 %, see “mice model 
limitations”.   
Because of this difference an alternative animal model could be considered. For instance, 
rats have shown to represent the human GM better than mice, due to a more similar 
Firmicutes : Bacteroidetes ratio and more similar genetic background  (Wos-oxley et al., 
2012). Even though rats would be better models for studying GM, considerations have 
been made in regards to the choice of mice. Inbred mice were chosen for our experiment 
due to the genetic similarities within the strain. If outbred mice were used the results most 
likely be affected by the different genotypes of the mice (Ling et al., 2014).  
All mice are fed equal amounts of dietary to further exclude this variable as well. The 
cages in which the mice were held were distributed randomly in the stable to exclude any 
fluctuating factors such as temperatures and light that might affect the GM composition 
of the different groups of mice.  
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It could be speculated that higher dosages of probiotics given to the dams, would change 
our results and show a transfer of altered GM composition from the mothers to the pups. 
The concentration of the probiotics given to the mice in this project was 1-4 *109 CFU 
per day, which is relatively high compared to the recommended daily dosage for adult 
humans, which are between 1010 – 2*1010 CFU per day (Kligler & Cohrssen, 2008). Since 
the GI tract in humans is longer and more complex than the GI tract in mice, see “mice 
model limitations”, the concentration of probiotics administered should be proportionally 
higher for humans, around 1011 CFU per day, to correspond to the concentration given 
mice. The high concentration of 109 CFU per day is given in the experiment to enhance 
the chances of observing an effect of the probiotics and inheritance of the GM from 
mother to pup.  
In a study by Ouwehand et al. they only administered 5 * 109 CFU per day of the exact 
same probiotics in the same ratio as we did, to observe a prevention of pollen-induced 
infiltration in humans (Ouwehand et al., 2009). This finding concludes that a smaller 
amount of probiotic can give positive results. We did not observe any altered GM 
composition and doubt that it is due to the concentration of the probiotics, since it is 
already very high. It could be suggested that the inheritance of a altered GM composition, 
due to probiotics, could occur if the mothers were given probiotics prior to pregnancy. 
When probiotics in a high concentration are given for a longer period of time, the 
possibility of gut colonization would increase (Crmonini et al., 2002; Williams, 2010). 
This colonization enables the probiotics to interfere with the adherence of occurring 
pathogens to intestinal mucosal cells and thereby becoming a part of the GM 
composition. This could increase the chance of inheritance from mother to pup (Williams, 
2010). To colonize the gut, the probiotics have to survive the passage through the GI 
tract. An experiment with probiotics in fermented milk by Pochart et al., 1992 has shown 
that the concentration of species B. bifidum and L. acidophilus decreases with 70-90 % of 
the administered dose when collected from the cecum. This result corresponds to a half-
life of about 40 min. for B. bifidum and L. acidophilus (Pochart et al., 1992). This means 
that the probiotics only stay in the GI tract for a short while and do not have the time to 
colonize. This does not exclude that the probiotics does not have an effect on the GM 
composition.    
Colonization might not be necessary for change in GM composition, which is shown in a 
study by Fujiwara et al. The study shows that the colonization by Bifidobacterium is 
unnecessary to obtain positive results in probiotic treatment. The bifidobacteria prevents 
the adhesion of pathogenic E. coli to receptors in the intestinal tract by producing the 
binding inhibitor proteinaceous (Fujiwara, Hashiba, Hirota, & Forstner, 1997). This 
competition between the probiotic and E. coli for adhesion sites might be enough to 
achieve positive results.  
The fact that we do not observe any changes in the GM composition in mothers given 
probiotic, could be due to lack of colonization, thus the probiotics only have indirect 
influence on the GM composition. 
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More stool samples could be collected to represent the development of the GM in the 
pups and in this way, observe when and if the GM composition is related to the first 
exposure to bacteria. If the meconium were collected after birth, it could be hypothesised 
that bacteria from the mother’s vagina would dominate the GM composition of the pup. If 
samples from the period of breastfeeding were collected, we would expect to observe the 
GM to be dominated by Bifidobacterium, since this species normally inhabits the breast 
milk (Salminen & Isolauri, 2006). In the period of weaning the mice were ingesting breast 
milk, normal food and faecal matter from the cages. The bacteria in the food might 
modulate the GM composition. Before ingestion of normal food the GM composition 
might resemble that of the mother, where transfer of probiotics could be observed. After 
ingestion this GM do not dominates any more. An improvement for this could be to 
collect the samples at the same day for both mothers and pup e.g. at day 21. 
 
The two earlier mentioned deviating bands seen in our result are too few for the statistic 
analysis to reveal any biological relevance since these bands were the only ones to differ, 
see figure 17. If we had chosen to use e.g. 16S rDNA sequencing on the excised bands we 
would get the exact sequence of the bacteria strains in the samples. In this way we could 
reveal the two strains of the deviating bands observed on the DGGE, which were 
significantly different between mice given probiotics and mice given PBS, see figure 17. 
In this way we could confirm or reject our hypothesis about the bands could be probiotics. 
If the two bands represent probiotic it could be suggested that an inheritance of the 
probiotic at least have occurred.  
Even though the two bands were the only ones with clear differences, it is possible that 
more bands exist that are different between probiotic and PBS treated mice in our gel. If 
two bands were placed at the same position in the gel, they would only represent one 
band with a high intensity. To expel the possibility of this, these postulates could possibly 
be tested by mixing known ratios of the two bacterial species, thereafter amplify and 
separate them on a DGGE gel to observe the intensities of these bands. 
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8 Conclusion 
The analysis of our results showed no significant difference between the treatment with 
probiotic and the control group. Based on this we conclude that probiotic treatment with 
Lactobacillus acidophilus and Bifidobacterium animalis lactis did not change the GM 
composition in the dams.  
Despite no difference between the two groups of mothers appeared, we did see a 100 % 
discrimination between the mothers and pups. Thus we cannot conclude whether an 
altered GM composition is inherited to the offspring without further investigation. The 
statistical analysis revealed only two deviating bands on the DGGE. These bands could 
possibly represent the probiotic strains. A16S rDNA sequencing is necessary to confirm 
our assumption that these bands represent probiotics. If the sequencing confirms presence 
of probiotics it could indicate a possible inheritance.  
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9 Further perspective  
Our project does not show any inheritance pattern of the GM composition from mice 
mothers to their pups. Even so our results are not conclusive and we cannot say that 
inheritance is not possible. Before anything conclusive can be said about the results 
further work with this project should be carried out.  
The experiment should be repeated and during the process focus should be on which 
changes could be done to minimize the limitations found within the experiment. If the 
timeframe was wider some changes and expansions would be beneficial.  
One modification could be enlargement of the group of mice. Instead of only five female 
mice in each of the four groups we could have extended the groups of pups. We could 
have included ten pups of each gender, so we would have 20 pups in the probiotic and the 
PBS, in total 40 pups to make the results more representative and as such give validation 
to the outcome. This could be done easily since the full-scale research project is doing 
their experiments with that amount of mice in each group and mix males and females.  
Mixing the genders would be beneficial since it has been shown that gender and GM 
composition may be correlated. Studies showed that there was no significant difference 
between gender and the GM while other population studies concluded that a significant 
difference was observed (Dicksved et al., 2007; Lay et al., 2005; Li et al., 2008; Mueller 
et al., 2006). There was found an abundance of Bacteriodes and Prevetola in males 
compared to females in one study while another study found a higher abundance of 
Clostridia, Bacteriodetes and Preoteobactera in males (Li et al., 2008; Mueller et al., 
2006). This correlation could be due to differences in hormones in the two genders, which 
indicates a possible interaction between hormones and GM.  
 
After a DGGE of the collected stool samples it would be interesting, and maybe increase 
our understanding of our results, to do a 16S rDNA sequence analysis of the genes found 
in the DGGE. The most interesting would be to do a sequencing on the bands, which 
differs among the groups since the different bands represent different bacteria species. 
Using the 16S rDNA gene sequence analysis allows us to determine and categorise the 
bacteria phylogenetically and taxonomically.  
 
A study by Karlsson showed that the probiotic strain Lactobacillus rhamnosus GG given 
to pregnant women was found in their infant's faeces at one and six months of age. The 
infants had not been exposed to probiotic directly but only indirectly by breastfeeding, 
like the pups in our experiment. Moreover, the study showed that infants could inherit a 
change GM composition, due to ingested probiotic, by their mothers (Karlsson, 2011).  
If we had observed a change in GM composition in our experiment these results could 
have been used by Barfod et al. as a confirmation of the possibility of change and inherit 
GM composition.  
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One theory is, that the change in GM composition can influence the LM via the immune 
defence system and might affect chronic inflammatory lung diseases, such as asthma. If it 
turns out that it is possible to change the composition of the LM in a way that affect 
asthma development, probiotic could have a prophylactic effect and treatment of children 
with high risk of developing asthma.  
In the study by Barfod et al., they expect to see differences in the reaction to induced 
asthma, based on the status of probiotic treatment. As mentioned they work with four 
groups of mice, and the hypothesis is to see a difference between probiotic treated mice 
and the control group when induced with OVA. In this part of the study, they only work 
with the two groups of pups, the ones born by probiotic treated mothers and the ones born 
by control group mothers. A difference between these groups would show inheritance of 
microbiota composition of both the gut and the lung presumably.  
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11 Appendix  
11.1 Appendix 1: Further description of the ongoing project.  
 
Introduction to the project: 
In earlier studies, the gut microbiota has been tested to observe differences in healthy 
people and in people with asthma. This was due to the assumption that healthy lungs was 
sterile and did not have a microbiome of its own, which could cause pulmonary diseases.  
Now it is becoming clearer that the lungs in fact are not sterile and the lung microbiota 
became a new field of research. An investigation of the lung microbiome might help 
understanding the development of pulmonary diseases – and to understand if a change in 
the composition of the lung microbiome might affect the development of diseases.  
To test the composition of the lung microbiome, it is necessary to figure out how it can be 
manipulated. Finding a way to manipulate the composition might be a step to find a way 
to avoid the development of pulmonary diseases.  
The ongoing project by Barfod et al. started three years ago; it set out to investigate the 
lung microbiome and the effect of probiotics in the development of asthma. The 
motivation for this project was an observed increase in the development of asthma in 
westernized countries. In Denmark the incidences of asthma has increased from 3.2% in 
1987 to 5.9% in 2000 (Linneberg, 2004).  
Barfod et al., have been working with the bacterial composition of the lung in BALB/cJ 
mice, since these are the most used models for inflammatory lung diseases (Barfod et al., 
2013). The bacterial composition was compared with the ones found in the intestine and 
the vagina. The vagina was examined, because it can have an influence on the 
development of the microbiome of the lungs, since it is the site for the first meeting with 
bacteria for the pup, when delivered naturally (Dominguez-bello et al., 2010).  
Barfod et al. found some overlap in the bacterial composition of the different tissue sites; 
the lung microbiome was distinct from the caecal, but had an overlap with the vaginal 
microbiome (Barfod et al., 2013). After these results it was tested, how and if the 
composition of the microbiota of the lung could be altered. Barfod et al. manipulate the 
microbiome of the lung and gut experimentally, showing that the lung microbiota is sex 
dependent and not just a reflection of the GM (Barfod et al., 2015).  A correlation 
between the gut – and lung microbiota is possibly that dysbiosis in the GM can play a role 
in development of pulmonary diseases. This could be an indirect effect via the immune 
stimulatory systemic effect. The changes in the GM affects the systemic immune defence, 
which can have an influence on how the immune defence reacts to bacteria in the lungs.  
The aim of the study was to investigate to what extent orally ingested perinatal probiotic 
can change immune priming, commensal bacteria in the gut and lung and susceptibility to 
mild experimental airway allergy in mice 
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Performance of the experiment  
In the experiment by Barfod et al. they have divided their mice into four groups. Each 
group consists of 20 mice as seen in figure 1.  
One female and male group of each receiving probiotics and PBS and are not injected by 
OVA, and one male and female group that were administrated by PBS and probiotic but 
also injected by OVA and Alum. The groups differ obviously in gender but also in 
age/size.  
 
 Figur 1 shows a detailed overview over the 4 mice group in the experiment.  
The BALB/cJ mice bred by mating two female with one male that were 10 weeks old for 
3 days. When the conception occurred they fed the groups with probiotics and PBS 
respectively.  
 The four groups were given 200 µl PBS or 200 µl probiotic suspension corresponding to 
approximately 1-4 x 109 CFU/day or PBS during the experiment.  
The probiotics given was Lactobacillus acidophilus NCFM (ATCC 700396), 
Bifidobacterium animalis lactis (B. lactis) Bl-04 (ATCC SD5219) and Bifidobacterium 
animalis ssp. lactis Bi-07 (ATCC SD5220). The pups born during the experiment were 
delivered naturally and stayed with their mothers and were breastfed. The pups were both 
female and male and were not given any probiotics directly. In that way the pups were 
divided into two groups as well, one group that suckled at mothers who were ingesting 
probiotics and pups that suckled with the control group of mothers.  
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When the pups became 10 days both the female and male were sensitized by injection 
with 1µg OVA and 1mg Alum. 10 days after injection (20 day old mice) in the period of 
weaning, the mice inhale 1% OVA in 20 min. The same procedure was carried out 3 days 
(23 day old mice) to induce asthma locally – For overview see figure 2.  
Two days after last exposure of OVA BAL and caecum samples were collected.  
From the samples the DNA were extracted using Qiagen spin protocol, amplified by a 
PCR reaction and run at a DGGE gel.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure	  2	  shows	  the	  timing	  of	  perinatal	  exposure	  and	  OVA	  treatment 
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11.2 Appendix 2 – DGGE 
Denaturing gradient gel electrophoresis is a method developed in the 1980’s for 
identification of point mutation and it has later been used to analyze microbial 
communities (Valaskova & Baldrian, 2009). The method is used in assessing microbial 
populations and has the advantage of not requiring previous knowledge of microbial 
population. Furthermore it is used to study interactions among and between 
microorganisms and the surrounding environment (Fatoudiarrassoubaly, 2007).  
DGGE is a molecular fingerprinting method that separates polymerase chain reaction 
(PCR)-generated DNA products (Peterson, 2007). Since this technique relies on PCR 
products, the DNA fragment which is suitable for studying bacteria is the rDNA more 
specific the 16S rDNA. The 16S rDNA is the DNA, which codes for the 16S RNA found 
within the 30S subunit in the 70S ribosome in bacteria (18S rRNA is found in eukaryotes 
and 16S rRNA in archae). In order to correctly initiate translation, the 3’end of the 16S 
rRNA base pair with a Shine-Dalgarno sequence of the mRNA (Griffinths et al., 2012).  
The 16S rDNA consist of 1,550 base pairs and have variable and conserved regions 
(Clarridge & Alerts, 2004). The conserved regions are present in almost all microbes and 
are used for primer complementation under DGGE (Duarte, Cássio, & Pascoal, 2007; 
Větrovský & Baldrian, 2013; Woo, Lau, Teng, Tse, & Yuen, 2008). Primers are 
complementary to the sequence at the beginning of the 16S rDNA gene and at either 540 
base pair region or at the end of the whole sequence (Clarridge & Alerts, 2004). The 
variable region in between the primers, are used for comparative taxonomy, because they 
have sufficient interspecific polymorphisms that provide statistically valid measurements 
that are distinguishable (Clarridge & Alerts, 2004; Relman, 1999). These slight changes 
are used as information about how close various organisms are related. Therefore 16S 
rDNA can be used as a universal phylogenic biomarker as this sequence fingerprints 
relatedness of various organisms (Clarridge & Alerts, 2004). 
 
 
 
 
 
 
 
Figure	  8	  shows the different steps in the PCR-DGGE procedure from Wiki 
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11.3 Appendix 3 – Protocols 
11.3.1 Flowchart – DNA extraction  
1 water sample (control) 
10 mother mice samples 
10 pups samples 
1 blank PCR with water 
Remember gloves 
Mark tubes (4 different tubes x 22) – the samples are marked according to the content   
All the faecal samples were kept on ice before use. 
 
Bacterial DNA extraction from fecal samples by Qiagen spin protocol: 
1. Add 1 fecal pellet, 300 µl zirconium beads (2/3 beads) (FIRMA), 1 sterile steel 
ball (FIRMA) and 1ml inhibitEX buffer into a 2 ml 
tube (total 22 tubes – 2 without fecal pellet, named: 
PCR and H2O). Sterile steel balls are washed with 
ethanol and chlorine and then stored in ethanol 
before use. Both zirconium beads and sterile steel 
balls disrupt the fecal pellet in the next step. 
NB! No sterile steel ball in sample 7M. 
2. The mix is disrupted by Tissue Lyser system 
(Qiagen): 
3. All samples (each 180-220 mg) are disrupted at 30 
HZ for 6 min. By Tissue Lyser system (Giagen). 
4. Short spin at 3000g in 4 min and incubated the mix 
in a heat block in 5 min. at 70°C (open up and 
disrupt) and 5 min. 95°C. 
5. Add 25 µl of proteinase K into a new 2 ml centrifuge 
tube 
6. Add 600 µl (fecal supernatant) into the 2ml tube with 
proteinase K. 
7. 600µl buffer AL is added, mixed and incubated for 
10 min at 70°C. 
8. 600µl ethanol (96-100%) is added to the lysate and 
vortexed (whirlmix short). 
9. 600µl lysate is transferred to the QIAamp spin 
column (silica) and centrifuged at 20,000x g for 1 
min and the filtrate is discarded. (the DNA is in the 
filter) 
10. 500 µl Buffer AW1 is added into the spin column 
and centrifuged at 20,000 x g for 1 min. and the 
filtrate is discarded. 
 
 
Samples  
1M mother -probiotica 
2M mother -probiotica 
3M mother -probiotica 
4M mother -probiotica 
5M mother -probiotica 
  
6M mother with probiotica 
7M mother with probiotica 
8M mother with probiotica 
9M mother with probiotica 
10M mother with probiotica 
  
  
1U pup -probiotica 
2U pup -probiotica 
3U pup -probiotica 
4U pup -probiotica 
5U pup -probiotica 
  
6U pup with probiotica 
7U pup with probiotica 
8U pup with probiotica 
9U pup with probiotica 
10U pup with probiotica 
  
PCR control 
H2O control 
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11. 500 µl Buffer AW2 is added into the spin column and centrifuged at 20,000 x g 
for 1 + 3 min. ⟶ the filtrate is discarded and centrifuged again at 20000 x g for 1 
min and the filtrate discarded. 
12. ATE buffer (elution buffer) is preheated to 65°C (elution of DNA from filter) 
13. The QIAamp spin column is transferred into a new labeled micro-centrifuge tube 
1,5 ml and 100µl ATE buffer is pipetted directly on a QIAamp membrane. 
14.  Kept at room temp for 3 minutes. 
15.  The sample is centrifuged at 20,000 x g for 1 min to elute DNA (DNA is in the 
tube – discard the filter). 
16.  Measurement of the DNA by Nanodrop measurements on each sample and stored 
at -80 °C. 
 
Reagents   
InhibitEX buffer It separate inhibitory substances from DNA and stops the 
enzymatic processes  
proteinase K This enzyme with very high specificity cleaves the caboxylic 
ends of aromatic, hydrophobic and aliphatic amino at 70 °C 
AL Lysis buffer, this contains chaotropic salts that inactivate 
deoxyribonucleases, which enzymatically digest DNA 
AW1 Wash buffer. This contain a low amount of chaotropic salt to 
remove any remaining proteins and coloured contaminants 
AW2 Wash buffer. This contains a high concentration of ethanol to 
remove the remaining salts.  
ATE Elution buffer  
 
Preparation of reagents  
InhibitEX Buffer (store at room temperature, 15–25°C)  
Mix InhibitEX Buffer thoroughly by shaking. If a precipitate has formed, incubate at 37–
70°C until it has fully dissolved.  
InhibitEX Buffer will exhibit a color change (orange) during storage; this does not affect 
the functionality of the buffer.  
 
Buffer AL* (store at room temperature)  
Mix Buffer AL thoroughly by shaking before use. If a precipitate has formed, incubate at 
70°C until it has fully dissolved.  
Buffer AL is stable for 1 year when stored closed at room temperature. Note: Do not add 
proteinase K directly to Buffer AL.  
 
Buffer AW1* (store at room temperature)  
Buffer AW1 is supplied as a concentrate. Before using for the first time, add 25 ml 
ethanol (96–100%) as indicated on the bottle.  
Buffer AW1 is stable for 1 year when stored closed at room temperature. Buffer AW1 
should be thoroughly mixed before use.  
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Buffer AW2† (store at room temperature)  
Buffer AW2 is supplied as a concentrate. Before using for the first time, add 30 ml 
ethanol (96–100%) to Buffer AW2 concentrate as indicated on the bottle.  
Buffer AW2 is stable for 1 year when stored closed at room temperature. Buffer AW2 
should be thoroughly mixed before use. 1	    
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
*Contains chaotropic salt. Take appropriate laboratory safety measure and wear gloves when handling. Not 
compatible with disinfecting agents that contain bleach. See page 5 for safety information. 
 † Contains sodium azide.  
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11.3.2 Flowchart - PCR  
1. The universal primer sets HDA1 and HDA2 (see table at the bottom) are diluted to 
5 pmol/µl.  
2. Mix the following and perform a PCR (total volume 50 µl). See pnkt 3 for PCR 
conditions 
-­‐ 4 µl PCR- water 
-­‐ 20 µl of 5 PRIME Mastermix (MasterMix-100Rxns, 5PRIME GmbH, 
Hamburg) 
-­‐ 8 µl of primer HDA 1f 
-­‐ 8 µl of primer HDA 2r  
-­‐  10 µl of DNA template 
PCR calculations: 
-­‐ 4 µl PCR- water* 25 rør= 100µl 
-­‐ 20 µl of 5 PRIME Mastermix *25= 500 µl 
-­‐ 8 µl of primer HDA 1f*25=200 µl 
-­‐ 8 µl of primer HDA 2r *25= 200µl 
-­‐ I alt = 1000 µl=1 ml (The above mentioned are added to a tube called MIX) 
-­‐  10 µl of DNA template*25=250 µl 
-­‐ 40µl MIX is added to each tube without the templat 
3. PCR:  
-­‐ Preheating step at 95 °C for 4 min. (Stage 1)) 
-­‐ Denaturation step for 30 sec in 94°C (Stage 2, gentages 35 gange) 
-­‐ Annealing step: 30 cycles at 56 °C for 30 sec (Stage 2, gentages 35 gange) 
-­‐  Elongation step at 68 °C for 60 sec (Stage 2, gentages 35 gange) 
-­‐ Extension step at 68 °C for 7 min (Stage 3) 
4. Run the PCR products on 0,2 % agarose gel 
5. View under UV illumination 
NB: 40 base-pair GC-clamp are placed on the 5’ end on the forward primer (HDA1). 
 
 
 
 
  
Forwardprimer 
(HDA1), position 
(338-357)  
(5´ACTCCACGGGAGGCAGCAGT´3) 
40 base-pair GC-
clamp of Forward 
primer  
(CGC CCG GGG CGC GCC CCG GGC GGG 
GCG GGGGCACGGGGG G). 
ReversePrimer 
(HDA2r) position 
539-561 
(5´GTA TTA CCG CGG CTG CTG GCA C´3) 
   
  
54 
11.3.3 Flowchart - DGGE 
Preparation of stock solutions 
Denaturing 0 % working solutions 
-­‐ Mix 20 ml 40 % bis-Acryl-Amide 
-­‐  2 ml 50×TAE buffer  
-­‐ Fill up to 100 ml with Milli.Q water.  
Denaturing 80% working solutions  
-­‐ Mix 32.0 ml deioniseret formamide (0.80×40 ml = 32 ml)  
-­‐ 20 ml 40 % bis-Acryl-Amide, 33.6 g urea (0.80×42 = 33.6 g) 
-­‐ 2 ml 50×TAE buffer  
-­‐ Fill up to 100 ml with Milli Q water.  
-­‐ Mix on a magnetic stirrer.  
Preparation of the glass plates  
-­‐ Clean glass plates 70 % ethanol before assembly.  
-­‐ A thin layer of Silicone vacuum grease is added to the straight edge of two 
spacers.  
-­‐ The spacers are then placed on the bigger plate and then the smaller plate is 
placed, on the two tops of spacers, to create a chamber in between (Figure 8 
A). 
-­‐ The plates are then mounted correctly onto the clamps and placed in the 
casting stand This was checked by filling it with Milli Q water and dried with 
filter paper  
Preparation of the Low and High gradient solution  
High and Low gradient solution preparation:  
1. The Solution of 10 % APS (ammonium-per-sulphate):  Dissolve 0.1 g of 
ammonium persulfate (APS) in 1 ml Milli Q water.  
2. Use 
-­‐ The denaturing solution (0%, 80%, 10 %) ammonium persulphate (APS) 
-­‐ N,N,N′,N′-tetramethylethylenediamine (TEMED)  
-­‐ Loading dye for the high solution in two 15 ml centrifuge tubes. 
The amount of low and high solutions. 
Used Material Gel 30-65 % Stacking Gel 
                                                 30 % Low 65 % High 0 % 
0 %, ml 7.5 2.25 6 
80 %, ml 4.5 9.75 - 
10 % APS, µl 100 100 80 
Loading dye µl 0 300 
TEMED, µl 12 12 8 
Total volume in ml 12 12 6 
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3. Centrifuge tubes containing High and Low solutions were mixed and poured into 
High and Low Gradient Marker. The pump is off and the gradient marker- 
channel is closed! 
4. The solutions gradient is simultaneously delivered with the wheel at 2.5.  
5. Fill the chamber carefully by needle nozzle that was connected to wheel and 
Gradient maker).  
6. Add 1 ml of the Milli Q water to the top of the gel to avoid dehydration of the gels  
7. Let the gel to polymerize for two hours.  
8. Dry the protective Milli Q water on the top of the gel by filter paper  
9. Insert the cam in-between the glasses, centrally, and add stacking gel slowly from 
the side of the cam  
10. Allow it to polymerize for 1 hour.   
 
Running the gel: 
1. Fill the DGGE aquarium with 7 L of 1x TAE buffer 
2. Preheat the buffer to 60 °C before loading the samples. 
3. Remove the casting stand and place the cooling core 
4. Fill with 1x TAE buffer before loading of the PCR products 
5. Preparation of the PCR products:  
-­‐ Add 5 µl of 6x MassRuler DNA loading dye to 30 µl of PCR product and 
markers. 
6. Insert the mixes into each DGGE gel lane. See the gel distribution below 
7. Transfer the clamped plates with cooling core into the DGGE aquarium 
8. Turn on the heater, voltmeter and the pump 
9. Run for 16 hours at 70 V.  
 
Staining of the gel: 
1. Mix (can be used ten times) 
-­‐ 225 ml Mili Q water  
-­‐ 25 ml 1 M NaCl 
-­‐ 75 µl GelRed* 
2. Stain the gel for 30 min 
3. Transfer the gel to the UV table and it will be viewed under illumination 
4. Take pictures and save as TIEF images 
 
*GelRed: DNA dye, which replaces high toxic ethidium bromid (EtBr) with flouroscent 
DNA dye. The structure of Gelred is closed related to ethidium bromid and the optical 
properties is identical. 
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Gel distribution 
 
Gel 1 (red):  
 
Gel 2 (black):  
 
Sample 1M – 5M mother with probiotics 
Sample 6M – 10M mother without probiotics 
Sample 1U – 5U pups with probiotics 
Sample 6U – 10U pups without probiotics 
 
M - marker 
 
 
 
 
 
 
 
 
 
  
lanes 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 
Loaded 
(PCR) 
DNA M 1 2 3 6 7 M 11 12 16 17 18 21 M DNA 
samples   1M 2M 3M 6M 7M  1U 2U 6U 7U 8U PCR   
lanes  1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 
Loaded 
(PCR) 
DNA M 4 5 8 9 10 M 13 14 15 19 20 22 M DNA 
samples   4M 5M 8M 9M 10M  3U 4U 5U 9U 10U H2O   
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11.5 Appendix 4: ANOVA test data 
 
  
ANOVA: Single factor 
      
        Mothers Pups 
 
RESUME 
    30 34 
 
Groups number Sum Mean Varians 
31 29 
 
Mothers 10 268 26,8 16,62222 
34 23 
 
Pups 10 286 28,6 44,26667 
23 20 
      26 30 
      28 29 
 
ANOVA 
    25 33 
 
Variations F P-value F crit 
 20 19 
 
Between groups 0,532117 0,475104 4,413873 
 26 25 
 
        
 25 24 
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11.6 Appendix 5: Certificate of Analysis (primers) 
 
 
Customer Name:
Customer
Customer No.
Order Number
Order ID
Order Date
Comments:
Anne-Karin Jensen
Det nat. Forsk.center for Arbejdsmiljø
1212-2
141209-0 19
09/ 12/20 14
Oligo ID: 141209J2D02 2/2DNA Olign Name: NEW HDAZr:
5’-GTA HA CCG CGG CTG CrG GCA C-3’
Synthesis Scale: 0.04 pmol No. Bases 22 Synthesised 5,8 OD Purification: RP-Columrr
Dissolve ifl: 255 p1 GC %: 63,6 Delivered 172 pg Delivery Form: Solid
Conc.: 100 pM 25,5 nmol Quality Control: MALDT-TOF
MW: 6727g/mol A3 C7 G7 T5 TM: 60.4°C
Comments:
&-JC,D IceSt / - pn2-Wcdc
141209-019
Page 1
Certificate of Analysis i I À
Tag Copenhagen AIS
Kong Georgs Vej 12
DK-2000 Frederiksberg
Denmark
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Introduction 
The interest for the human gut microbiota 
(GM) has increased in the recent years. The 
human GM consists of a complex community 
of up to 100 trillion bacteria, representing 
between 500 and 1000 different species 
(Turnbaugh et al., 2007).  
The GM has been associated with a wide range 
of diseases, which questions its correlation to 
different metabolic relationships within the 
human physiology (Guinane & Cotter, 2013; 
Nguyen et al., 2015).  
The GM establishes when microbes colonize 
intestinal habitats after birth and this indicates 
a possible inheritance of the GM to the 
offspring. It has been shown that microbial 
communities in newborns closely resembles 
those found in the mother (Dominguez-Bello 
et al., 2010).  
The GM can be disrupted due to factors like 
diet, antibiotics, and hygiene. The cooperation 
and functional stability between the GM and 
the host become imbalanced leading to 
dysbiosis. This imbalance can be compensated 
for by ingestion of probiotics, which confer 
health benefits for the host (Bengmark, 1998; 
Dongarrà et al., 2013; Maranduba et al., 2015). 
These benefits include; decreased adhesion of 
pathogens to the epithelium, decreased 
colonization of pathogens in the host, and 
regulation of immune cells (Bengmark, 1998). 
The most frequently probiotics used are the 
Lactobacillus and Bifidobacterium species 
(Kligler & Cohrssen, 2008). 
Many questions regarding to GM remains 
unanswered. Therefore, this study aims to 
investigate if probiotics alter the microbiota 
composition and if this potential change is 
inherited from mother to offspring by using a 
mouse model. Mice were provided from 
another project that aims to investigate the 
correlation between lung microbiota, usage of 
probiotics and the development of asthma.  
Methods 
A mouse model was applied to investigate the 
effects of probiotic treatment on the GM and 
the possibility of inheritance.  
The probiotics used were L. acidophilus 
NCFM (ATCC 700396) and B. animalis ssp. 
lactis Bl-04 (ATCC SD5219). We used 20 
BALB/cJ female mice in total; 10 of them were 
mothers and 10 were their respective pups, see 
figure 1. Half the mothers received probiotics 
from conception, during pregnancy and until 
day 21 after giving birth. The mice were given 
approximately 1-4 x 109 CFU/day. The 
 
Resume of “The influence of probiotics on gut 
microbiota inheritance in mice” 
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1Department of Nature, Systems and Models, Roskilde University, 2015 
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experiment ran for 42 days for mothers and 46 
days for pups from mating to termination, see 
figure 1. 
Faecal samples were collected from mice 
given a combination of two probiotics, a 
control group, and the pups from both groups. 
DNA extraction using QIAamp Fast DNA 
stool mini kit, the PCR amplification, and 
finally DGGE were performed. The primers 
for the PCR were designed to match the 
variable regions V3 and V4 of the 16S rDNA 
gene.  
Results 
Each band on the DGGE corresponds to a 16S 
rDNA amplified product from the bacterial 
strain, see figure 2 (a + b).  
Both dendrogram and PCA shows clear 
separation between mothers and pups. The 
clustering analysis does not show a clear 
separation between PBS and probiotic treated 
mice.  
The discriminant analysis gives a separation 
between the four groups based upon the group-
specific bands; this separation is based on two 
bands.  
  
The Kruskal-Wallis test was used to test for 
differences between all four groups and the 
Mann-Whitney test used to test for differences 
between the mothers and pups, and PBS 
treated mice and probiotic treated mice, 
respectively. 
The group separation was determined with the 
Jackknife method, and the results are shown in 
table 1. The results indicate that there is a 
general poor separation between the four 
groups, but that the mothers are well separated 
from the pups. Furthermore, the probiotic 
treated groups is not separated clearly from the 
PBS treated groups. 
 
The tests show no correlation of treatments 
within the two groups, probiotic or PBS, but it 
makes 100% discrimination between mothers 
and pups, represented by the zero values in 
table 1.  
Table 1: Recognition rates based on the paired groups. 
Figure 1 shows an overview by a timeline over our experiment. The mice are mated for three days preceded by 2 
weeks of acclimatization to the stables. The mice conceive on day -21. The pregnancy lasted for 21 days, day -21 
up to day 0. On day 0 the pups were born vaginally and stayed in the cage with their mothers. The pups suckled 
up until day 10, where they were weaned afterwards. On day 21 the faecal samples of the mothers were collected 
and the mothers were terminated. The samples from the pups were collected at day 25 where they were 
terminated. 
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Discussion 
As probiotic are administered to one group of 
mice, a higher number of bands and a higher 
diversity in these mice were expected. The 
results did not confirm this. 
A high probiotic concentration was given to 
mice in ratio to their body weight to observe an 
altered GM composition. This assumption was 
because colonization by probiotics in the gut 
would be increased by administering a very 
high concentration in ratio to bodyweight for a 
long period of time (Crmonini et al., 2002; 
Williams, 2010). The fact that we do not 
observe any changes in the GM composition in 
mothers given probiotics, could be due to lack 
of colonization, thus the probiotics only have 
indirect influence on the GM composition. 
Fujiwara et al. suggest that a colonization 
might not be necessary to change the GM 
composition. They also show that the 
colonization by Bifidobacterium is 
unnecessary to obtain positive results in 
Figure 2:a) and b) show the two photographed gels (colour inverted).  The outside lanes marked “DNA” were added for stability in 
order to reduce “frowning”, c) shows the clustering analysis on a dendrogram, d) The PCA analysis shows a separation of mothers 
and pups, e) By discriminant analysis the probiotic group are separated  from the PBS group,  
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probiotic treatment (Fujiwara et al., 1997). 
Additionally the half-life time of the probiotics 
B. bifidum and L. acidophilus is estimated to 
be 40 min. (Pochart et al., 1992).  
It could be suggested that the inheritance of an 
altered GM composition, due to probiotics, 
could occur if the mothers were given 
probiotics prior to pregnancy (Crmonini et al., 
2002; Williams, 2010). This colonization 
enables the probiotics to interfere with the 
adherence of occurring pathogens to intestinal 
epithelium. 
The two discriminating bands seen in our result 
are too few for the statistical analysis to reveal 
any biological relevance. If we had chosen to 
use e.g. 16S rDNA sequencing on the excised 
bands we would get the exact sequence of the 
bacteria strains in the samples. In this way, we 
could reveal the two strains of the deviating 
bands observed on the DGGE, which were 
significantly different between mice given 
probiotics and mice given PBS.  
Even though the two bands were the only ones 
with clear differences, it is possible that more 
bands exist that are different between probiotic 
and PBS treated mice in our gel. If two bands 
were placed at the same position in the gel, 
they would only represent one band with a high 
intensity. To expel the possibility of this, these 
postulates could possibly be tested by mixing 
known ratios of the two bacterial species, 
thereafter amplify and separate them on a 
DGGE gel to observe the intensities of these 
bands. 
Conclusion  
Our project does not show any inheritance 
pattern of the GM composition from mice 
mothers to their pups. Furthermore, the 
analysis of our results did not show any 
significant difference between the treatment 
with probiotic and the control group. Based on 
this we conclude that probiotic treatment did 
not change the GM composition in the dams. 
Thus, we cannot conclude whether an altered 
GM composition is inherited to the offspring 
without further investigation. Even so, our 
results are not conclusive and we cannot say 
that inheritance is not possible. Before 
anything conclusive can be said about the 
results further, work with this project should be 
carried out.   
Further perspective  
For further studies, it would be of interest to 
investigate the two strains of the deviating 
bands observed on the DGGE. The most 
interesting would be to do a sequencing on the 
bands, which differs among the groups since 
the different bands represent different bacteria 
species with 16S rDNA. Using the 16S rDNA, 
gene sequence analysis allows us to determine 
and categorise the bacteria phylogenetically 
and taxonomically.  
If we had observed a change in GM 
composition in our experiment these results 
could have been used by Barfod et al., 201 )as 
a confirmation of the possibility of change and 
inherit GM composition. Thus, GM 
composition can influence the lung microbiota 
via the immune defence system and might 
affect chronic inflammatory lung diseases. 
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